Table 3.
Characteristics of KRAS mutants.
| KRAS positive (n = 47) | Wild type (n = 71) | p | |
|---|---|---|---|
| Gender | 0.43 | ||
| Male | 19 (40.4%) | 34 (47.9%) | |
| Female | 28 (59.6%) | 37 (52.1%) | |
| Age at diagnosis | 0.48 | ||
| Years: median (range) | 68 (46–82) | 69 (35–91) | |
| Smoking status | 0.02 | ||
| Never | 1 (2.1%) | 13 (18.3%) | |
| Former | 36 (76.6%) | 41 (57.7%) | |
| Current | 10 (21.3%) | 17 (23.9%) | |
| Nodule volume (cc) | 2.5 (0.2–22.4) | 2.0 (0.2–14.5) | 0.19 |
| CANARY prognosis | 0.06 | ||
| G | 7 (14.9%) | 4 (5.6%) | |
| I | 25 (53.2%) | 52 (73.2%) | |
| P | 15 (31.9%) | 15 (21.1%) |